CDXS logo

CDXS
Codexis Inc.

2,352
Mkt Cap
$238.08M
Volume
1.39M
52W High
$3.87
52W Low
$0.9583
PE Ratio
-4.65
CDXS Fundamentals
Price
$2.41
Prev Close
$2.62
Open
$2.60
50D MA
$1.59
Beta
2.05
Avg. Volume
4.19M
EPS (Annual)
-$0.5046
P/B
4.32
Rev/Employee
$482,102.74
$136.56
Loading...
Loading...
News
all
press releases
Codexis, Inc. (NASDAQ:CDXS) Short Interest Down 35.6% in March
Codexis, Inc. (NASDAQ:CDXS - Get Free Report) saw a significant drop in short interest in March. As of March 31st, there was short interest totaling 6,938,356 shares, a drop of 35.6% from the March...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
537,833 Shares in Codexis, Inc. $CDXS Purchased by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL purchased a new position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 537,833 shares of the biotechnology company's stock, va...
MarketBeat·8d ago
News Placeholder
Aberdeen Group plc Raises Stake in Codexis, Inc. $CDXS
Aberdeen Group plc boosted its position in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 94.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and...
MarketBeat·14d ago
News Placeholder
Short Interest in Codexis, Inc. (NASDAQ:CDXS) Grows By 26.2%
Codexis, Inc. (NASDAQ:CDXS - Get Free Report) saw a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling 9,161,843 shares, an...
MarketBeat·1mo ago
News Placeholder
Codexis (NASDAQ:CDXS) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen upgraded shares of Codexis from a "strong sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours?
Codexis shares jumped 37.8% in after-hours trading after the company reported a profitable fourth quarter and full-year 2025 revenue growth.read more...
Benzinga·1mo ago
News Placeholder
Codexis (CDXS) Q4 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·1mo ago
News Placeholder
Codexis Q4 Earnings Call Highlights
Codexis (NASDAQ:CDXS) used its fourth-quarter and full-year 2025 earnings call to highlight progress behind its strategic focus on RNA medicines, with management emphasizing technical milestones for...
MarketBeat·1mo ago
News Placeholder
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of +2,100.00% and +1.61%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Codexis (NASDAQ:CDXS) Releases Earnings Results, Beats Expectations By $0.10 EPS
Codexis (NASDAQ:CDXS - Get Free Report) announced its quarterly earnings results on Wednesday. The biotechnology company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.01 by...
MarketBeat·1mo ago
<
1
2
...
>

Latest CDXS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.